Next Article in Journal
Assessment of Knowledge, Attitude and Barriers towards Pharmacovigilance among Physicians and Pharmacists of Abbottabad, Pakistan
Next Article in Special Issue
Benzodiazepines Withdrawal: Initial Outcomes and Long-Term Impact on Falls in a French Nursing Home
Previous Article in Journal
The Relevancy of paracetamol and Breastfeeding Post Infant Vaccination: A Systematic Review
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessArticle
Pharmacy 2018, 6(2), 28; https://doi.org/10.3390/pharmacy6020028

De-Prescribing of Psychotropic Medications in the Adult Population with Intellectual Disabilities: A Commentary

Daughters of Charity Disability Support Services, D15 DH6F, Dublin, Ireland
Received: 23 January 2018 / Revised: 27 March 2018 / Accepted: 27 March 2018 / Published: 30 March 2018
(This article belongs to the Special Issue Deprescribing)
Full-Text   |   PDF [214 KB, uploaded 3 May 2018]

Abstract

The population with intellectual disabilities is one of the most vulnerable groups in society. Medication use is the main therapeutic intervention in this population and psychotropic medications can be prescribed for mental health conditions and for challenging behaviors. Clinical experience of prescribers and pharmacists working with people with intellectual disabilities suggests that reducing or stopping psychotropic medication is not always straightforward. What is required is rational, rather than rationed, prescribing of psychotropic medications. Concerns of clinicians working with people with intellectual disabilities and both formal and informal carers can result in maintenance of the ‘status quo.’ Setting-related, carer-related and staff-related factors play an important role in the real world of people with intellectual disabilities. Optimizing medication regimens in the adult population with intellectual disabilities is complicated but it is recognized that efforts to improve the current state of medication utilization are required for many individuals with intellectual disabilities. Pharmacists have a responsibility to include the person and/or their carer in their efforts to promote optimization of psychotropic medication use in environment in which the person lives. View Full-Text
Keywords: intellectual disabilities; psychotropic; pharmacist; de-prescribing; medicines optimization; vulnerable population; risk intellectual disabilities; psychotropic; pharmacist; de-prescribing; medicines optimization; vulnerable population; risk
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Flood, B. De-Prescribing of Psychotropic Medications in the Adult Population with Intellectual Disabilities: A Commentary. Pharmacy 2018, 6, 28.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmacy EISSN 2226-4787 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top